Paying users zone. Data is hidden behind: .
Get 1-month access to AbbVie Inc. for $19.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Price to Operating Profit (P/OP)
since 2012
Beginner level
Calculation
AbbVie Inc., P/OP, long-term trends, calculation
| P/OP | = | Share price1, 2, 3 | ÷ | Operating profit per share1 | Operating profit per share1 | = | Operating earnings1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2018 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2017 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2016 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2015 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2014 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2013 | = | ÷ | = | ÷ | |||||||
| Dec 31, 2012 | = | ÷ | = | ÷ |
Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20), 10-K (filing date: 2014-02-21), 10-K (filing date: 2013-03-15).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of AbbVie Inc.’s Annual Report.
Comparison to Competitors
AbbVie Inc., P/OP, long-term trends, comparison to competitors
| AbbVie Inc. | Abbott Laboratories | Allergan PLC | Amgen Inc. | Biogen Inc. | Gilead Sciences Inc. | Illumina Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2019 | |||||||||
| Dec 31, 2018 | |||||||||
| Dec 31, 2017 | |||||||||
| Dec 31, 2016 | |||||||||
| Dec 31, 2015 | |||||||||
| Dec 31, 2014 | |||||||||
| Dec 31, 2013 | |||||||||
| Dec 31, 2012 |
Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20), 10-K (filing date: 2014-02-21), 10-K (filing date: 2013-03-15).